Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies
Gut and Liver · 2025
DOI: 10.5009/gnl250008 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Gut and Liver, 2025. Verfasst von Jiayi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, State Key Lab of Digestive Health, National Clinical Research Center …. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B, Chronic, Liver, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, State Key Lab of Digestive Health, National Clinical Research Center of Digestive Diseases, Beijing Key Laboratory of Translational Medicin…
- Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China.
ORCID-Profile: Jiayi Zhang, Shuyan Chen, Jialing Zhou, Bingqiong Wang, Xiaoning Wu, Xiaoqian Xu, Xinyu Zhao, Yuanyuan Kong, Xiaojuan Ou, Yameng Sun, Hong You
Förderung
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhang, J., Chen, S., Zhou, J., Wang, B., Wu, X., Xu, X., Zhao, X., Kong, Y., Ou, X., Sun, Y., & You, H. (2025). Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies. Gut and Liver. https://doi.org/10.5009/gnl250008
Vancouver
Zhang J, Chen S, Zhou J, Wang B, Wu X, Xu X, et al. Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies. Gut and Liver. 2025. doi:10.5009/gnl250008
BibTeX
@article{Zhang2025,
author = {Zhang, Jiayi and Chen, Shuyan and Zhou, Jialing and Wang, Bingqiong and Wu, Xiaoning and Xu, Xiaoqian and Zhao, Xinyu and Kong, Yuanyuan and Ou, Xiaojuan and Sun, Yameng and You, Hong},
title = {Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies},
journal = {Gut and Liver},
year = {2025},
doi = {10.5009/gnl250008}
}
EUVIMED